These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28842679)

  • 41. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.
    Yang M; Liu Q; Huang T; Tan W; Qu L; Chen T; Pan H; Chen L; Liu J; Wong CW; Lu WW; Guan M
    Theranostics; 2020; 10(24):10874-10891. PubMed ID: 33042259
    [No Abstract]   [Full Text] [Related]  

  • 42. The marine compound and elongation factor 1A1 inhibitor, didemnin B, provides benefit in western diet-induced non-alcoholic fatty liver disease.
    Wilson RB; Chen YJ; Sutherland BG; Sawyez CG; Zhang R; Woolnough T; Hetherington AM; Peters KM; Patel K; Kennelly JP; Leonard KA; Schuurman M; Jacobs RL; Wang R; Borradaile NM
    Pharmacol Res; 2020 Nov; 161():105208. PubMed ID: 32977024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
    Saeed WK; Jun DW; Jang K; Ahn SB; Oh JH; Chae YJ; Lee JS; Kang HT
    World J Gastroenterol; 2018 Dec; 24(48):5477-5490. PubMed ID: 30622377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
    Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
    Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
    Li X; Wang Z; Klaunig JE
    Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of a ubiquitously expressed receptor in the vertebrate olfactory system.
    DeMaria S; Berke AP; Van Name E; Heravian A; Ferreira T; Ngai J
    J Neurosci; 2013 Sep; 33(38):15235-47. PubMed ID: 24048853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
    Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
    Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic autophagy fluctuates during the development of non-alcoholic fatty liver disease.
    Ding H; Ge G; Tseng Y; Ma Y; Zhang J; Liu J
    Ann Hepatol; 2020; 19(5):516-522. PubMed ID: 32553647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2.
    Kim JH; Jung DY; Nagappan A; Jung MH
    Sci Rep; 2018 Sep; 8(1):13734. PubMed ID: 30214048
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Niacin Ameliorates Hepatic Steatosis by Inhibiting De Novo Lipogenesis Via a GPR109A-Mediated PKC-ERK1/2-AMPK Signaling Pathway in C57BL/6 Mice Fed a High-Fat Diet.
    Ye L; Cao Z; Lai X; Shi Y; Zhou N
    J Nutr; 2020 Apr; 150(4):672-684. PubMed ID: 31858105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-100 overexpression attenuates high fat diet induced weight gain, liver steatosis, hypertriglyceridemia and development of metabolic syndrome in mice.
    Smolka C; Schlösser D; Hohnloser C; Bemtgen X; Jänich C; Schneider L; Martin J; Pfeifer D; Moser M; Hasselblatt P; Bode C; Grundmann S; Pankratz F
    Mol Med; 2021 Sep; 27(1):101. PubMed ID: 34488621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drosophila odorant receptors are both ligand-gated and cyclic-nucleotide-activated cation channels.
    Wicher D; Schäfer R; Bauernfeind R; Stensmyr MC; Heller R; Heinemann SH; Hansson BS
    Nature; 2008 Apr; 452(7190):1007-11. PubMed ID: 18408711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved Glucose Intolerance through a Distinct Mouse Olfactory Receptor 23-Induced Signaling Pathway Mediating Glucose Uptake in Myotubes and Adipocytes.
    Kang W; Zhang K; Tong T; Park T
    Mol Nutr Food Res; 2020 Dec; 64(23):e1901329. PubMed ID: 32918394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
    Hong Y; Choi SI; Hong E; Kim GH
    J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel small molecule AdipoR2 agonist ameliorates experimental hepatic steatosis in hamsters and mice.
    Zhao Y; Sun N; Song X; Zhu J; Wang T; Wang Z; Yu Y; Ren J; Chen H; Zhan T; Tian J; Ma C; Huang J; Wang J; Zhang Y; Yang B
    Free Radic Biol Med; 2023 Jul; 203():69-85. PubMed ID: 37044149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glial Cell Line-Derived Neurotrophic Factor Enhances Autophagic Flux in Mouse and Rat Hepatocytes and Protects Against Palmitate Lipotoxicity.
    Mwangi SM; Li G; Ye L; Liu Y; Reichardt F; Yeligar SM; Hart CM; Czaja MJ; Srinivasan S
    Hepatology; 2019 Jun; 69(6):2455-2470. PubMed ID: 30715741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The transcription cofactor CRTC1 protects from aberrant hepatic lipid accumulation.
    Kim H
    Sci Rep; 2016 Nov; 6():37280. PubMed ID: 27869139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
    Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
    Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.
    Kim JH; Jung DY; Kim HR; Jung MH
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167594
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism.
    Zhou R; Yi L; Ye X; Zeng X; Liu K; Qin Y; Zhang Q; Mi M
    Cell Physiol Biochem; 2018; 51(5):2397-2420. PubMed ID: 30537742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.